Oncolys BioPharma Market Cap

Oncolys BioPharma has a market cap or net worth of 76.54 billion as of June 23, 2026. Its market cap has increased by 448.05% in one year.

Market Cap

76.54B

Enterprise Value

73.73B

Revenue

28.55M

Ranking

n/a

PE Ratio

n/a

Stock Price

2,673.00

Market Cap Chart

Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 76.54B, an increase of 224.07%. That is a compound annual growth rate of 9.82%.

Market Cap History

Date	Market Cap	% Change
Jun 23, 2026	76.54B	93.35%
Dec 30, 2025	39.59B	207.33%
Dec 30, 2024	12.88B	18.41%
Dec 29, 2023	10.88B	19.14%
Dec 30, 2022	9.13B	-0.44%
Dec 30, 2021	9.17B	-58.26%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GNI Group	141.04B
PeptiDream	123.33B
Nxera Pharma	88.82B
SanBio Company	79.78B
Healios K.K.	34.83B
Cuorips	31.87B
Japan Tissue Engineering	25.67B
Renascience	22.18B

Market Cap Rankings